Delivery Order SPE2DB24D2100-SPE2DB24FBCXA

Award Date 8/8/24
Potential Completion Date 8/9/24
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at a ceiling of $1,008.82, is for the delivery of NAYZILAM 5 MG NASAL SPRAYS. The contract is a Firm Fixed Price Delivery Order with a completion date of September 26, 2024. Amerisourcebergen, a major pharmaceutical distributor, provides a wide range of medical supplies and prescription drugs to various government...
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order to AmerisourceBergen Drug Corporation for the supply of NAYZILAM 5 MG nasal sprays. The $1,008.39 firm fixed-price contract has an ultimate completion date of August 30, 2022. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this order, which does not have a set-aside designation. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The award, valued at $1,118.63, is a Delivery Order contract with the Defense Logistics Agency (DLA) for the supply of NAYZILAM 5 MG NASAL SPRAYS. The contract has a firm fixed price pricing type and an ultimate completion date of September 4, 2024. Amerisourcebergen is a large pharmaceutical distributor...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,314.12 firm-fixed-price delivery order is for the supply of NAYZILAM 5 MG NASAL SPRAYS, a medication used to treat seizures. The contract has an ultimate completion date of August 13, 2024 and is not set aside for any specific business categories. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The contract, valued at up to $1,008.39, is for the delivery of 4565068572 NAYZILAM 5 MG NASAL SPRAYS. This is a firm fixed-price delivery order contract with a completion date of July 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, through its Corporate Office division, is a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical for $1,539.69 to provide NAYZILAM 5 MG NASAL SPRAYS. The contract has a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is not associated with any set-aside designations. The company also holds an indefinite delivery contract with DLA,...
This federal contract award is a delivery order valued at $2,168.72 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of NAYZILAM 5 MG NASAL SPRAYS, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of March 7, 2025 and is a firm fixed-price type. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,047.25, is for the delivery of NAYZILAM 5 MG NASAL SPRAYS. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of NAYZILAM 5 MG NASAL SPRAYS. The contract is a firm fixed-price delivery order with a ceiling value of $1,974.49 and a period of performance through February 26, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which...
The Defense Logistics Agency (DLA) has awarded a $2,530.57 firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of NAYZILAM 5 MG NASAL SPRAYS. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to Amerisourcebergen Drug Corp. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies...
  • SPE2DB24D2100
    Indefinite Delivery Contract
  • SPE2DB24D2100-SPE2DB24FBCXA
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor, was made by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,352.91 firm-fixed-price delivery order is for the supply of NAYZILAM 5 MG NASAL SPRAYS. This award is not associated with a set-aside program. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The current delivery order, with a completion date of August 9, 2024, is part of this broader IDC vehicle.

Generated 11/7/24, 9:42 AM